Conferencias Magistrales 2017


C O N F E R E N C I A S     M A G I S T R A L E S  

en el 

52° CONGRESO MEXICANO DE QUÍMICA, 

36° CONGRESO NACIONAL DE EDUCACIÓN QUÍMICA

 Y LA EXPO QUÍMICA 2017

  " La Química nos une"

a celebrarse del 26 al 29 de septiembre 2017, en Puerto Vallarta, Jalisco, México, teniendo como sede Hotel The Westin Resort & Spa Puerto Vallarta 

 
Prof. Paul J. Chirik 

Department of Chemistry

Princeton University

Princeton, NJ

 

Edwards S. Sanford Professor of Chemistry

B.S., Virginia Tech, 1995

Ph.D., California Institute of Technology, 2000, Advisor: John Bercaw

 

Education 

Doctor of Philosophy, Chemistry April, 2000

California Institute of Technology, Pasadena, CA

Advisor: Professor John E. Bercaw

Dissertation: Ancillary Ligand Effects on Fundamental Transformations in Metallocene Catalyzed Olefin Polymerization.

 

Most Synergistic Activities

•Editor-in-Chief, Organometallics

•Associate Director for External Partnerships, Andlinger Center

•Chair, Inorganic Reaction Mechanisms Gordon Conference

Other activities

 

Overview

Current fundamental projects are focused in the areas with base Metal Catalysis

In Electronic Structure Studies, Asymmetric Alkene Hydrogenation, Hydrogen Isotope Exchange, C-H Functionalization, Alkene Cycloaddition, Alkene and Alkyne Reduction and Cross Coupling 

Selected Honors and Awards 

•Winner, Presidential Green Chemistry Challenge (2016)

•First JSCC International Award for Creative Work (2015)

•Closs Lecturer, University of Chicago (2014)

•Dalton Lecturer, University California – Berkeley (2011)

•Winner, Blavatnik Award for Young Scientists, NYAS (2009)

•Arthur C. Cope Scholar Award, American Chemical Society (2009)

other awards

 

For more details, visit the group''s website:

http://chemists.princeton.edu/chirik/ 

http://chemists.princeton.edu/chirik/files/2014/04/Chirik_CV_web_2016-01-02.pdf 

Prof. Ramon Vilar

Faculty of Natural Sciences, Department of Chemistry

Professor of Medicinal Inorganic Chemistry   

Imperial London College

 

His research focuses on the following areas:

•Medicinal Inorganic Chemistry

•Chemical Biology

•Molecular recognition and self-assembly

•Molecular Imaging

 

Overview

Synthesis of metal-containing drugs and study of their interactions with

DNA (as potential anticancer drugs) and proteins (as inhibitors of phosphatases).

Development of metal-containing probes for biomedical imaging (MRI and optical)

Organometallic chemistry of palladium (cross-coupling reactions, development of fast chemical processes for PET labelling)

Development of receptors for selective recognition of anions (phosphate, chloride, arsenate) and cations (mercury, lead) for the development of chemical sensors

Anion templated synthesis of supramolecular assemblies

Most Publications

Marković T, Manzoor S, Humphreys-Williams E, et al., 2017, Experimental Determination of Zinc Isotope Fractionation in Complexes with the Phytosiderophore 2'-Deoxymugeneic Acid (DMA) and Its Structural Analogues, and Implications for Plant Uptake Mechanisms., Environ Sci Technol, Vol:51, Pages:98-107

Ang DL, Harper BWJ, Cubo L, et al., 2016, Quadruplex DNA-Stabilising Dinuclear Platinum(II) Terpyridine Complexes with Flexible Linkers, Chemistry-a European Journal, Vol:22, ISSN:0947-6539, Pages:2317-2325

 

For more details, visit the group''s website:

http://www3.imperial.ac.uk/medinchem

http://www.imperial.ac.uk/vilar-research-group 

Prof. László Kürti

Department of Chemistry

Rice University

Houston, TX

Synthetic organic chemistry is the critical foundation for the medical application of many complex organic molecules (i.e., natural products or drug molecules); it is the only way to produce these complex molecules in sufficient quantities for studies or clinical and commercial use. Moreover, synthetic chemistry enables the design and the preparation of novel drug molecules that can be used to study fundamental biological pathways or change the course of various diseases.

More than three quarters of known organic molecules and the overwhelming majority of currently used drug molecules contain heterocycles, yet the number of highly efficient methods to prepare these types of compounds is surprisingly low. I plan to address this deficiency in my research program, which will have a dual focus. On the one hand, my group will develop novel catalytic enantioselective transformations and apply these reactions for the rapid assembly of various heterocycles and carbocycles. Secondly, these hetero- and carbocyclic motifs are present in numerous natural products with potent biological activities, therefore we will have the opportunity to design and quickly prepare a large number of derivatives and screen them in a variety of assays to identify new drug leads. These newly developed methods will also allow the enantioselective preparation of other highly functionalized compounds that may be utilized for the catalysis of dozens of organic transformations.

My research program does not only seek to develop new and powerful transformations in organic chemistry and enable the synthesis of biologically relevant compounds to aid drug discovery, but it also provides an excellent platform for the education and training of both undergraduate and graduate students. The strongly interdisciplinary environment in the BioScience Research Collaborative (BRC) at Rice University allows my research group to pursue these goals and find many opportunities for fruitful collaboration

 

For more details, visit the website: 

https://chemistry.rice.edu/FacultyDetail.aspx?p=6F84F7BD8729F155 

http://kurtilabs.com/publications/ 

http://kurtilabs.com/about-laszlo/ 

Dra. Lena Ruiz Azuara 

Departamento: Química Inorgánica y Nuclear, Universidad Nacional Autónoma de México

Áreas de investigación:

•Química Inorgánica y Nuclear - Química Bioinorgánica.

•Química Inorgánica y Nuclear - Innovación y desarrollo de la enseñanza de la Química.

•Química Inorgánica y Nuclear - Química de Coordinación (elementos del bloque D).

•Química Inorgánica y Nuclear - Química organometálica.

•Química Inorgánica y Nuclear - Química Inorgánica Medicinal. 

Se sintetizan y caracterizan ligantes polidentados, donadores de N, O, S y sus compuestos metálicos y como compuestos quelatos mixtos, heterolépticos.

Desarrollo de fármacos de base metálica, desde el diseño, estudios químicos, pruebas biológicas principalmente antineoplásicos y antiparasitarios, así como estudios preclínicos y fases clínicas

Premios y distinciones más recientes :

•Miembro distinguido de la Royal Society of Chemistry 

•SNI Nivel III del Área 2

•Premio CANIFARMA 2007 en el área de Medicamentos de uso Humano, Investigación Básica

•Reconocimiento Ciudad Capital “Heberto Castillo Martínez” con la creación del Premio “Lena Ruiz Azuara”, en el área de Ciencias Básicas, 2007

Publicaciones relevantes:

1. Lorena Becco, Alejandra Rodríguez, María Elena Bravo, Ma. José Prieto, Lena Ruiz Azuara, Beatriz Garat, Virtudes Moreno, Dinorah Gambino. New achievements on biological aspects of copper complexes Casiopeínas ®; interaction with DNA and proteins and anti-Trypanosoma cruzi activity. Journal of Inorganic Biochemistry. 109 (2012) 49-56.

2. María Elena Bravo-Gómez, Silvia Dávila-Manzanilla, Jessica Flood-Garibay, Miguel Ángel Muciño-Hernández, Angel Mendoza, Juan Carlos García-Ramos, Rafael Moreno-Esparza, Lena Ruiz-Azuara. Secondary ligand effects on the cytotoxicity of several Casiopeína’s group II compounds. Journal of the Mexican Chemical Society. 2012, 56(1), 85-92 ISSN 1870-249X aceptado diciembre 14, 2011 (Issue Dedicated to Dra. Estela Sánchez)

Para conocer más detalles en http://www.quimica.unam.mx/ficha_investigador.php?ID=157&tipo=2 

 

 

 

1 2 3 4 5 6 7 8 9 10 11 12
jquery slider by WOWSlider.com v8.6
Full Reviw on best bokkmakers by http://artbetting.net/
Download Premium Templates
Bookmaker No1 in The UK - William Hill by w.artbetting.net